Published in Genet Med on April 01, 2010
Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med (2011) 1.75
Family history of type 2 diabetes and prevalence of metabolic syndrome in adult Asian Indians. J Cardiovasc Dis Res (2012) 0.97
"You don't have to keep everything on paper": African American women's use of family health history tools. J Community Genet (2013) 0.92
Family history of cardiovascular disease, perceived cardiovascular disease risk, and health-related behavior: a review of the literature. J Cardiovasc Nurs (2014) 0.91
Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention. Clin Trials (2011) 0.91
Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention. Diabetes Res Clin Pract (2012) 0.89
The impact of personalized risk feedback on Mexican Americans' perceived risk for heart disease and diabetes. Health Educ Res (2014) 0.89
Veterans' experience in using the online Surgeon General's family health history tool. Per Med (2011) 0.86
Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination. Psychol Health (2012) 0.86
Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial. Genet Med (2011) 0.84
Impact of delivery models on understanding genomic risk for type 2 diabetes. Public Health Genomics (2014) 0.81
The context of collecting family health history: examining definitions of family and family communication about health among African American women. J Health Commun (2015) 0.78
Genetic risk, perceived risk, and cancer worry in daughters of breast cancer patients. J Genet Couns (2010) 0.78
Heart disease risk and self-efficacy in overweight and obese adults. J Nurse Pract (2017) 0.75
The Prognostic Value of Family History for the Estimation of Cardiovascular Mortality Risk in Men: Results from a Long-Term Cohort Study in Lithuania. PLoS One (2015) 0.75
Clinical utility of a Web-enabled risk-assessment and clinical decision support program. Genet Med (2016) 0.75
Using web-based familial risk information for diabetes prevention: a randomized controlled trial. BMC Public Health (2013) 0.75
The Health Belief Model: a decade later. Health Educ Q (1984) 25.48
Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med (1987) 3.88
Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med (2003) 3.55
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med (2003) 2.99
Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med (2004) 2.93
Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet (1997) 2.79
Family history-taking in community family practice: implications for genetic screening. Genet Med (2001) 2.75
Unrealistic optimism about susceptibility to health problems. J Behav Med (1982) 2.47
The genetic family history as a risk assessment tool in internal medicine. Genet Med (2003) 2.35
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr (1999) 2.15
New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J Am Med Inform Assoc (2008) 2.14
Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med (2009) 2.07
Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med (1999) 1.83
Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med (2006) 1.77
'Coming down the line'-- patients' understanding of their family history of common chronic disease. Ann Fam Med (2005) 1.68
Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med (2006) 1.67
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev (2003) 1.53
Predicting risk behaviors: development and validation of a diagnostic scale. J Health Commun (2000) 1.43
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer (2007) 1.43
Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Family and friends with disease: their impact on perceived risk. Prev Med (2003) 1.31
Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med (2008) 1.24
Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial. Diabetes Care (2009) 1.21
Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology (2004) 1.17
Impact of genetic testing on causal models of heart disease and arthritis: An analogue study. Psychol Health (2000) 1.15
Familial risk assessment for early-onset coronary heart disease. Genet Med (2006) 1.14
Predictors of perceived risk for colon cancer in a national probability sample in the United States. J Health Commun (2006) 1.11
How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating? J Eval Clin Pract (2001) 1.06
Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population. Genet Med (2006) 1.06
Underestimation of breast cancer risk: influence on screening behavior. Oncol Nurs Forum (2009) 1.03
Self-rated cardiovascular risk and 15-year cardiovascular mortality. Ann Fam Med (2008) 1.02
Expanding the definition of a positive family history for early-onset coronary heart disease. Genet Med (2006) 0.91
Cancer risk and risk communication in urban, lower-income neighborhoods. Prev Med (2009) 0.82
Family history and prevalence of diabetes in the US population: 6-year results from the National Health and Nutrition Examination Survey (NHANES, 1999 2004). Diabetes (2007) 0.82
ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res (2013) 9.31
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet (2012) 4.45
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38
Continuity of primary care: to whom does it matter and when? Ann Fam Med (2004) 3.77
A practice change model for quality improvement in primary care practice. J Healthc Manag (2004) 3.73
Prevalence of multiple chronic disease risk factors. 2001 National Health Interview Survey. Am J Prev Med (2004) 3.63
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA (2007) 3.62
Dose escalation of a curcuminoid formulation. BMC Complement Altern Med (2006) 3.59
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07
New knowledge for and about primary care: a view through the looking glass of the Annals of Family Medicine. Ann Fam Med (2006) 2.81
A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens (2003) 2.76
Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics? Med Decis Making (2005) 2.43
The genetic family history as a risk assessment tool in internal medicine. Genet Med (2003) 2.35
Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med (2005) 2.35
Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. Am J Prev Med (2012) 2.30
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials (2008) 2.29
Infrastructure requirements for practice-based research networks. Ann Fam Med (2005) 2.16
Essential characteristics of effective Balint group leadership. Fam Med (2004) 2.11
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev (2008) 1.99
Genetic control of mammalian meiotic recombination. I. Variation in exchange frequencies among males from inbred mouse strains. Genetics (2002) 1.90
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.85
Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med (2006) 1.84
Sustainability of a practice-individualized preventive service delivery intervention. Am J Prev Med (2003) 1.80
Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med (2011) 1.75
Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut (2007) 1.68
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Tailored interventions for multiple risk behaviors. Health Educ Res (2002) 1.58
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol (2003) 1.53
Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine (2009) 1.53
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) (2013) 1.49
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials (2008) 1.48
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) (2008) 1.47
Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.45
Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res (2004) 1.41
Time use during acute and chronic illness visits to a family physician. Fam Pract (2003) 1.39
Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management. Cancer (2004) 1.39
Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med (2011) 1.38
Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res (2009) 1.30
Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res (2008) 1.29
Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract (2004) 1.27
Racial, ethnic, and socioeconomic differences in the incidence of obesity related to childbirth. Am J Public Health (2008) 1.25
Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med (2008) 1.24
Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. J Clin Oncol (2006) 1.20
Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med (2008) 1.18
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 1.17
Genome-wide analysis of antisense transcription with Affymetrix exon array. BMC Genomics (2008) 1.17
Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J Proteome Res (2011) 1.14
Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol (2012) 1.14
Informed consent for pediatric phase 1 cancer trials: physicians' perspectives. Cancer (2010) 1.13
Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med (2005) 1.13
Creating a culture of inquiry in family medicine. Fam Med (2014) 1.11
Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) (2008) 1.11
Racial, gender, and socioeconomic status bias in senior medical student clinical decision-making: a national survey. J Gen Intern Med (2015) 1.11
Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA). J Genet Couns (2011) 1.10
The role of the champion in primary care change efforts: from the State Networks of Colorado Ambulatory Practices and Partners (SNOCAP). J Am Board Fam Med (2012) 1.09
Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psychooncology (2008) 1.08
Stability of parental understanding of random assignment in childhood leukemia trials: an empirical examination of informed consent. J Clin Oncol (2006) 1.08
On the nature and analysis of clustered data. Ann Fam Med (2004) 1.08
Serum metabolomic analysis of pancreatic cancer--letter. Cancer Epidemiol Biomarkers Prev (2013) 1.07
Emotional disorders in primary care. J Consult Clin Psychol (2002) 1.07
What is lacking in current decision aids on cancer screening? CA Cancer J Clin (2013) 1.06
Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer (2008) 1.06
Groups potentially at risk for making poorly informed decisions about entry into clinical trials for childhood cancer. J Clin Oncol (2003) 1.05
Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer (2008) 1.05
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res (2011) 1.05
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res (2014) 1.04
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res (2009) 1.04
Physician-elder interaction in community family practice. J Am Board Fam Pract (2004) 1.04
Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet C Semin Med Genet (2006) 1.02
Gender differences in time spent during direct observation of doctor-patient encounters. J Womens Health (Larchmt) (2004) 1.02
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer (2007) 1.01
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res (2009) 1.01
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One (2010) 1.01
Measuring discord in treatment decision-making; progress toward development of a cancer communication and decision-making assessment tool. Psychooncology (2006) 1.01
Biomarkers of Psychological Stress in Health Disparities Research. Open Biomark J (2008) 0.99
The Cancer Communication Assessment Tool for Patients and Families (CCAT-PF): a new measure. Psychooncology (2008) 0.98
Family history assessment: impact on disease risk perceptions. Am J Prev Med (2012) 0.97